Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Saturday, October 19, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - WEDNESDAY, FEBRUARY 26TH, 2014
Previous Mid Day Report Next Mid Day Report >>>

DOW 16218.57 38.91 (0.24%) | NASDAQ 4309.58 21.99 (0.51%) | S&P 500 1849.43 4.31 (0.23%)
Time of Screening : 2/26/2014 12:29:16 PM         Report Released : 2/26/2014 1:34:07 PM
Price is: Above 52W High and Less Than 52W High but within 10% of the 52 Week High
Volume Is: At least 90% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
JAZZ - NASDAQ
Jazz Pharmaceuticals Plc
$164.90 -10.09
-5.76%
$169.80 2,108,314
219.62% of 50 DAV
50 DAV is 960,000
$176.60
-6.63%
9/30/2013 $93.20 PP = $89.10
MB = $93.56
Most Recent Note - 2/26/2014 1:01:41 PM
G - Gapped down today retreating from its all-time high. It is very extended from any sound base. Reported earnings +12% on +28% sales revenues for the Dec '13 quarter, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. Its 50 DMA line ($144) and recent lows in the $135 area define important support to watch on pullbacks where violation s may trigger technical sell signals.
>>> The latest Featured Stock Update with an annotated graph appeared on 2/21/2014. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M
QCOR - NASDAQ
Questcor Pharmaceuticals
$76.30 -2.35
-2.99%
$79.43 3,415,825
173.22% of 50 DAV
50 DAV is 1,972,000
$80.25
-4.92%
2/26/2014 $76.30 PP = $74.86
MB = $78.60
Most Recent Note - 2/26/2014 1:19:28 PM
Y - Pulling back for a 2nd consecutive session today with higher volume, action indicating distributional pressure. Color code is changed to yellow with pivot point cited based on its 8/16/13 high plus 10 cents. Technically, it broke out with a volume-driven gain on 2/18/14 triggering a technical buy signal. Reported earnings +53% on +51% sales revenues for the Dec '13 quarter, continuing its streak of strong quarterly earnings increases satisfying the C criteria. Found support at its 200 DMA line then rebounded from a deep slump since dropped from the Featured Stocks list on 9/20/13 due to technical deterioration after members were cautioned - "A breach of the prior low ($60.31 on 9/11/13) may trigger a more worrisome technical sell signal."
>>> The latest Featured Stock Update with an annotated graph appeared on 8/26/2013. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M
VRX - NYSE
Valeant Pharmaceuticals
$148.63 +3.57
2.46%
$150.17 1,286,248
91.16% of 50 DAV
50 DAV is 1,411,000
$148.73
-0.07%
9/11/2013 $100.26 PP = $105.50
MB = $110.78
Most Recent Note - 2/26/2014 1:30:47 PM
G - Due to report Dec '13 quarterly results on Thursday. Hitting new all-time highs again today, getting very extended from any sound base. Its 50 DMA line and recent lows coincide near $130 defining important near-term support to watch.
>>> The latest Featured Stock Update with an annotated graph appeared on 2/10/2014. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
ANIK - NASDAQ - DRUGS - Biotechnology
Anika Therapeutics Inc
$50.78 +16.31
47.30%
$52.49 $39.40 28.87% 4,299,079
1,452.39%
296,000
Most Recent Note for ANIK - 2/26/2014 12:33:36 PM
Considerable "breakaway gap" and new 52-week high with today's volume-driven gain on news of arthritis drug receiving FDA approval. Undercut its 50 DMA line during its consolidation since last noted with caution in the 11/27/13 mid-day report - "No overhead supply remains to act as resistance. Reported earnings +200% on +20% sales revenues for the Sep '13 quarter, above the +25% minimum earnings guideline for a 4th consecutive quarterly comparison (C criteria). Its up and down annual earnings (A criteria) history leaves fundamental concerns. Recently found support near its 50 DMA line. In the past year it went through a deep consolidation below its 200 DMA line then rebounded impressively and topped its 2012 high ($17.70)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ASBI - NASDAQ - BANKING - Savings & Loans
Ameriana Bancorp
$13.42 -0.11
-0.81%
$13.53 $14.26 -5.89% 3,464
173.20%
2,000
Most Recent Note for ASBI - 2/26/2014 12:34:16 PM
Prior mid-day reports have repeatedly cautioned members concerning this thinly traded stock - "Consolidating in a tight range in recent months, perched near its 50 DMA line and 52-week high. Earnings history is not a match with the fact-based investment system's fundamental guidelines (C and A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
AVGO - NASDAQ - ELECTRONICS - Semiconductor - Integrated Circuits
Broadcom Inc
$61.86 +2.86
4.85%
$63.49 $60.00 3.10% 3,051,908
138.98%
2,196,000
Most Recent Note for AVGO - 2/26/2014 12:36:35 PM
Hitting new 52-week and all-time highs with another volume-driven gain today. Reported earnings +29% on +23% sales revenues for the quarter ended Jan 31, 2014 versus the year ago period. Prior quarterly comparisons were persistently below the fact-based system's +25% minimum earnings guideline (C criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CLR - NYSE - ENERGY - Oil &; Gas Drilling &; Explorati
Continental Res Inc
$121.37 -2.03
-1.65%
$124.55 $124.54 -2.55% 1,064,112
95.52%
1,114,000
Most Recent Note for CLR - 2/26/2014 12:40:13 PM
Perched at its 52-week and all-time highs after a recent spurt of volume-driven gains. Undercut its 50 DMA line during its consolidation then rebounded since last noted with caution in the 11/19/13 mid-day report. Reported earnings +85% on +70% sales revenues for the Sep '13 quarter marking its 3rd consecutive quarter above the +25% minimum earnings guideline (C criteria). Prior mid-day reports cautioned members - "Prior earnings history has been erratic and not a match with the investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CLRO - NASDAQ - Telecom-Infrastructure
ClearOne Inc
$12.50 +1.71
15.85%
$14.30 $10.97 13.95% 224,235
934.31%
24,000
Most Recent Note for CLRO - 2/26/2014 12:44:36 PM
Hitting another new 52-week high with today's 4th consecutive big volume-driven gain. Earnings increases were above the +25% minimum guideline (C criteria) in the 3 latest quarterly comparisons through Sep '13 but sales revenues increases and its annual earnings (A criteria) history do not match with the fact-based system's guidelines. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ECPG - NASDAQ - FINANCIAL SERVICES - Credit Services
Encore Capital Group Inc
$50.56 +1.10
2.22%
$51.11 $51.95 -2.68% 242,566
102.35%
237,000
Most Recent Note for ECPG - 2/26/2014 12:47:27 PM
Perched within close striking distance of its 52-week and all-time highs today while consolidating above its 50 DMA line in an orderly fashion building a sound base. Reported earnings +33% on +65% sales revenues for the Dec '13 quarter, a 2nd quarter with greatly improved results, but fundamental concerns remain. Prior mid-day report cautioned members - "Reported earnings +2% on +11% sales revenues for the Jun '13 quarter marking its 3rd consecutive quarterly comparison below the +25% minimum earnings guideline (C criteria). It survived but failed to impress since dropped from the Featured Stocks list on 10/08/12."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
EOG - NYSE - Oil&Gas-U S Expl&Prod
E O G Resources Inc
$186.96 +2.96
1.61%
$188.41 $188.30 -0.71% 1,791,026
95.17%
1,882,000
Most Recent Note for EOG - 2/26/2014 12:50:28 PM
Touched a new 52-week high with today's 3rd consecutive volume-driven gain. Reported earnings +24% on +24% sales revenues for the Dec '13 quarter. The 5 prior quarterly comparisons showed impressive earnings increases above the +25% minimum guideline (C criteria). Undercut its 50 DMA line during its consolidation then rebounded since last noted with caution in the 10/23/13 mid-day report - "Erratic annual earnings (A criteria) history is cause for concern."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ESTE - AMEX - Oil&Gas-U S Expl&Prod
Earthstone Energy Inc
$21.93 -0.34
-1.52%
$22.50 $22.50 -2.52% 5,573
139.33%
4,000
Most Recent Note for ESTE - 2/26/2014 12:51:38 PM
Perched near its 52-week high today. The 2/25/14 mid-day report cautioned members - "Reported strong sales revenues and earnings increases in the 3 latest quarterly comparisons through Dec '13 satisfying the C criteria. Technically, it broke out with a gap up and volume-driven gain on 2/14/14 and followed through with additional confirming gains for new 52-week highs. Faces some resistance at multi-year highs in the $25-26 area. There is a very small supply of only 1.25 million shares (S criteria) in the float and only 3 top-rated funds (I criteria) own its shares."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
FRGI - NASDAQ - LEISURE - Restaurants
Fiesta Restaurant Group
$51.52 +3.40
7.07%
$52.07 $53.08 -2.94% 491,370
139.20%
353,000
Most Recent Note for FRGI - 2/26/2014 12:55:02 PM
Found support above prior highs in the $38 area and above its 200 DMA line during its consolidation since last noted with caution in the 11/15/13 mid-day report after completing a new Public Offering. Reported earnings +67% on +8% sales revenues for the Dec '13 quarter, but fundamental concerns remain. Prior mid-day reports cautioned - "Earnings history is not a match with the fact-based investment system's guidelines (C & A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HEI - NYSE - AEROSPACE/DEFENSE - Aerospace/Defense Products & Services
Heico Corp
$61.45 +3.16
5.42%
$62.69 $62.30 -1.36% 320,755
150.59%
213,000
Most Recent Note for HEI - 2/26/2014 12:58:30 PM
Hitting a new 52-week high with today's gap up and considerable gain backed by above average volume following strong earnings news for the Jan '14 quarter. Fundamental concerns remain with respect to the C criteria. Weak technical action prompted it to be dropped from the Featured Stocks list on 1/17/08.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
JLL - NYSE - REAL ESTATE - Property Management/Developmen
Jones Lang Lasalle Inc
$123.09 +0.11
0.09%
$124.66 $123.87 -0.63% 363,583
97.21%
374,000
Most Recent Note for JLL - 2/26/2014 1:03:59 PM
Reported earnings +28% on +21% sales revenues for the Dec '13 quarter but fundamental concerns remain. Prior quarterly earnings per share increases were below the +25% minimum guideline (C criteria). Research shows that earnings growth is the single most important indicator of a stock's potential to make a big price move.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LIOX - NASDAQ - INTERNET - Internet Software & Services
Lionbridge Technologies
$7.40 +0.40
5.71%
$7.50 $7.43 -0.40% 747,375
142.90%
523,000
Most Recent Note for LIOX - 2/26/2014 1:04:37 PM
Hitting yet another new 52-week high with today's volume-driven gain. While tallying volume-driven gains for new highs prior mid-day reports cautioned members - "Reported strong earnings increases in the Sep and Dec '13 quarters but fundamental concerns remain with respect to the C and A criteria. Technically broke out on 2/04/14 with a considerable volume-driven gain. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MGIC - NASDAQ - COMPUTER SOFTWARE & SERVICES - Application Software
Magic Software Enter Ltd
$9.69 +0.66
7.30%
$9.83 $9.27 4.53% 198,590
143.91%
138,000
Most Recent Note for MGIC - 2/26/2014 1:05:40 PM
Gapped up today hitting another new 52-week high with a big volume-driven gain, rallying with no resistance remaining due to overhead supply. Reported earnings +14% on +13% sales revenues for the Dec '13 quarter. Prior mid-day reports repeatedly cautioned members - "This Israel-based Computer - Tech Services firm's quarterly earnings history has been below the +25% minimum guideline (C criteria) but improved in the Sep '13 quarter. It has a strong annual earnings (A criteria) history. Low priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MIDD - NASDAQ - MANUFACTURING - Diversified Machinery
Middleby Corp
$298.82 +35.11
13.31%
$302.85 $267.34 11.78% 262,278
240.62%
109,000
Most Recent Note for MIDD - 2/26/2014 1:11:22 PM
Considerable "breakaway gap" today for new 52-week and all-time highs, quickly distancing itself from prior highs near $260. Reported earnings +29% on +29% sales revenues for the Dec '13 quarter, beating expectations. Now 3 of the past 4 quarterly comparisons have shown earnings increases above the +25% minimum earnings guideline (C criteria). Found support near its 50 DMA line and proved resilient since dropped from the Featured Stocks list on 4/18/13.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PEBK - NASDAQ - BANKING - Regional - Mid-Atlantic Banks
Peoples Bancorp Nc
$15.61 -0.04
-0.26%
$15.70 $16.40 -4.82% 8,540
106.75%
8,000
Most Recent Note for PEBK - 2/26/2014 1:12:30 PM
Perched near its 52-week high today, stubbornly holding its ground following recent volume-driven gains. Prior mid-day reports repeatedly cautioned members concerning this thinly-traded stock - "Earnings history is not a match with the fact-based investment system's fundamental guidelines (C and A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PZZA - NASDAQ - LEISURE - Restaurants
Papa Johns Intl Inc
$51.74 +3.15
6.48%
$52.35 $49.33 4.89% 316,339
106.87%
296,000
Most Recent Note for PZZA - 2/26/2014 1:13:23 PM
Powering to new 52-week and all-time highs with today's 3rd consecutive volume-driven gain. Prior mid-day reports cautioned members - "The Louisville, KY based pizza firm's up and down annual earnings (A criteria) history, lack of great sales revenues growth, and quarterly earnings comparisons mostly below the +25% minimum guideline (C criteria) leave fundamental concerns. Superior buy candidates under the investment system's guidelines always showed strong sales revenues increases indicative of great demand for their products or services."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
QLTY - NASDAQ - TRANSPORTATION - Trucking
Quality Distribution Inc
$14.03 +0.04
0.25%
$14.32 $15.07 -6.93% 590,802
233.52%
253,000
Most Recent Note for QLTY - 2/26/2014 1:21:22 PM
Undercut its 50 DMA line as it gapped down today, yet it found prompt support and managed a "positive reversal" from early lows. Reported earnings +18% on +5% sales revenues for the Dec '13 quarter. Prior mid-day reports repeatedly cautioned members - "Completed a Secondary Offering 8/08/13 and found support above its 200 DMA line during the latest consolidation. Quarterly and annual earnings history (C and A criteria) has been below the fact-based investment system's guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
RDY - NYSE - DRUGS - Drug Manufacturers - Other
Dr Reddys Labs Ltd Adr
$47.03 +1.85
4.09%
$47.38 $45.53 3.29% 387,264
187.99%
206,000
Most Recent Note for RDY - 2/26/2014 1:24:36 PM
Gapped up today rallying for new 52-week highs with a 3rd consecutive gain adding to a spurt of volume-driven gains into new high territory. No overhead supply remains to act as resistance. This India-based firm in the Medical - Generic Drugs industry group has not shown strong and steady quarterly and annual earnings increases (C and A criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SGC - NASDAQ - Comml Svcs-Outsourcing
Superior Group of Companies
$16.64 +0.23
1.40%
$16.64 $16.97 -1.94% 7,330
104.71%
7,000
Most Recent Note for SGC - 2/26/2014 1:27:35 PM
This thinly-traded stock is perched within close striking distance of its 52-week high with today's 3rd consecutive gain on ever-increasing volume. Reported earnings +79% on +46% sales revenues for the Dec '13 quarter. Prior quarterly and annual earnings increases (C and A criteria) have not been strong and steady enough to meet the fact-based investment system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
YY - NASDAQ - INTERNET - Content
Joyy Inc
$75.94 +5.11
7.22%
$76.91 $72.78 4.34% 1,666,323
95.93%
1,737,000
Most Recent Note for YY - 2/26/2014 1:33:55 PM
Hitting new 52-week and all-time highs with today's big volume-driven gain. It did not form a sound base pattern yet found support above prior highs in the $56 area during its choppy consolidation after dropped from the Featured Stocks list on 1/27/14 amid widespread weakness in China-related companies.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us